摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-溴-2-(甲氧基甲基)苯 | 52711-30-5

中文名称
1-溴-2-(甲氧基甲基)苯
中文别名
2-溴苄基甲醚;1-溴苄基甲醚
英文名称
1-bromo-2-(methoxymethyl)benzene
英文别名
2-bromobenzyl methyl ether;2-(methoxymethyl)bromobenzene
1-溴-2-(甲氧基甲基)苯化学式
CAS
52711-30-5
化学式
C8H9BrO
mdl
——
分子量
201.063
InChiKey
QFAZLCRHLRJNAW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    213℃
  • 密度:
    1.388
  • 闪点:
    84℃

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    10
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    1

安全信息

  • 危险品标志:
    Xi
  • 海关编码:
    2909309090
  • 危险性防范说明:
    P280,P305+P351+P338
  • 危险性描述:
    H302
  • 储存条件:
    室温避光保存

SDS

SDS:8a0d4e870dcaddafe9276019822ca442
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 1-Bromo-2-(methoxymethyl)benzene
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 1-Bromo-2-(methoxymethyl)benzene
CAS number: 52711-30-5

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H9BrO
Molecular weight: 201.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-溴-2-(甲氧基甲基)苯N-溴代丁二酰亚胺(NBS) 作用下, 以 四氯化碳 为溶剂, 反应 1.0h, 以60%的产率得到邻溴苯甲醛
    参考文献:
    名称:
    用 NBS 氧化苄基甲基醚,选择性地提供芳香醛或芳香甲酯
    摘要:
    苄基甲基醚的单溴化或二溴化可以通过控制 NBS 的量和温度来实现。从单溴化中间体中去除甲基溴产生芳香醛,而二溴化中间体的水解以良好的产率提供芳香甲基酯。
    DOI:
    10.1021/jo1004313
  • 作为产物:
    描述:
    参考文献:
    名称:
    .alpha.-phenylacrylic acid derivatives, their preparation and their use
    摘要:
    .alpha.-苯基丙烯酸衍生物 I n=0至4;y=a;R.sup.1=H;烷基;烯烃基;炔基;取代或未取代的环烷基;当W是直接键时,为乙烯基或乙炔基;R.sup.2=CN;烯烃基;炔基;取代或未取代的环烷基;取代或未取代的烷基;R.sup.3=H;NO.sub.2;CN;卤素;烷基;烷氧基;卤代烷基;卤代烷氧基;烷硫基;或当n为2、3或4时,两个相邻的取代基R.sup.3一起形成取代或未取代的1,3-丁二烯-1,4-二基;R.sup.4是苯基,携带一个基团--CR.sup.7.dbd.NO--R.sup.8,并且可能进一步携带一个或两个基团;W=直接键;氧;硫;取代或未取代的氮;A可以是氧或硫基团。
    公开号:
    US05298527A1
点击查看最新优质反应信息

文献信息

  • [EN] 2,3-DISUBSTITUTED 1 -ACYL-4-AMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS BROMODOMAIN INHIBITORS<br/>[FR] DÉRIVÉS 2,3-DISUBSTITUÉS DE 1-ACYL-4-AMINO-1,2,3,4-TÉTRAHYDROQUINOLÉINE ET LEUR UTILISATION COMME INHIBITEURS DE BROMODOMAINES
    申请人:GLAXOSMITHKLINE IP NO 2 LTD
    公开号:WO2014140076A1
    公开(公告)日:2014-09-18
    The present invention relates to novel compounds of formula (I), wherein R1 is C1-4alkyl; R2 is C1-4alkyl, C3-7cycloalkyl, -CH2CF3, -CH2OCH3 or heterocyclyl; R3 is C1-4alkyl, -CH2F, -CH2OH or -CH2O(O)CH3; R4 when present is as defined in claim 1; R5 when present is H, halo, hydroxy or C1-6alkoxy; A is -NH-, -O-, -S-, -SO-, -SO2-, -N(C1-4alkyl)- or -NC(O)(CH3)-; V is phenyl, heteroaromatic or pyridone any of which may be optionally substituted by 1, 2 or 3 substituents; W is CH or N; X is C or N; Y is C or N; and Z is CH or N; subject to the proviso that no more than 2 of W, X, Y and Z are N, pharmaceutical compositions containing such compounds and to their use as bromodomain inhibitors.
    本发明涉及式(I)的新化合物,其中R1为C1-4烷基;R2为C1-4烷基、C3-7环烷基、-CH2CF3、-CH2OCH3或杂环烷基;R3为C1-4烷基、-CH2F、-CH2OH或-CH2O(O)CH3;R4存在时如权利要求1所定义;R5存在时为H、卤素、羟基或C1-6烷氧基;A为-NH-、-O-、-S-、-SO-、-SO2-、-N(C1-4烷基)-或-NC(O)(CH3)-;V为苯基、杂芳基或吡啶酮,其中任何一个可以选择性地被1、2或3个取代基取代;W为CH或N;X为C或N;Y为C或N;Z为CH或N;但W、X、Y和Z中不超过2个为N,含有这种化合物的药物组合物以及它们作为溴结构域抑制剂的用途。
  • “Xanthene” is a premium bridging group for xanthenoid dyes
    作者:Jin Li、Mengmeng Zhang、Lu Yang、Yubing Han、Xiao Luo、Xuhong Qian、Youjun Yang
    DOI:10.1016/j.cclet.2021.04.041
    日期:2021.12
    Novel xanthenoid dyes by replacing the central oxygen atom of the xanthene dyes with less electron-rich bridging groups have been intensively sought after primarily for their long spectral wavelengths. However, the new scaffolds are likely prone to nucleophilic attack at their central methine carbon, as the result of the reduced electron density of the fluorochromic scaffolds. We envisage that the
    主要由于长光谱波长,人们一直在强烈地寻求通过用较少的富含电子的桥连基团代替the吨染料的中心氧原子的新型类黄酮染料。然而,由于荧光变色支架的电子密度降低,新的支架可能易于在其中心次甲基碳上发生亲核攻击。我们设想桥接基团可用于从进入的亲核试剂上空间屏蔽中心次甲基碳,并提供高稳定性和合成的x吨-x吨染料。另外,可以通过亲电子芳族取代来修饰黄嘌呤桥连基团以引入官能团,例如磺酸酯基团。
  • METAL-LIGAND COMPLEX, OLEFIN POLYMERIZATION CATALYST DERIVED THEREFROM, AND OLEFIN POLYMERIZATION METHOD UTILIZING THE CATALYST
    申请人:DOW GLOBAL TECHNOLOGIES LLC
    公开号:US20160311837A1
    公开(公告)日:2016-10-27
    A metal-ligand complex has formula (I): wherein J, L, M, R 1 , R 2 , R 3 , R 4 , X, p, q, and r are defined herein. The metal-ligand complex is useful as a catalyst or catalyst precursor for olefin polymerization.
    一个金属-配体配合物具有公式(I):其中J、L、M、R1、R2、R3、R4、X、p、q和r在此处定义。该金属-配体配合物作为烯烃聚合的催化剂或催化剂前体是有用的。
  • Inhibitors of c-Jun N-terminal kinases
    申请人:Liu Gang
    公开号:US20060173050A1
    公开(公告)日:2006-08-03
    The present invention relates to compounds that are inhibitors of c-jun N-terminal kinase 1, 2, or 3 (JNK1, JNK2, or JNK3), compositions containing the compounds and the use of the compounds in the prevention or treatment of disorders regulated by the activation of JNK1, JNK2 and JNK3.
    本发明涉及作为c-jun N-末端激酶1、2或3(JNK1、JNK2或JNK3)抑制剂的化合物,包含这些化合物的组合物以及这些化合物在预防或治疗由JNK1、JNK2和JNK3激活调控的疾病中的用途。
  • Pd-Catalyzed Carbonylative α-Arylation of Aryl Bromides: Scope and Mechanistic Studies
    作者:Dennis U. Nielsen、Camille Lescot、Thomas M. Gøgsig、Anders T. Lindhardt、Troels Skrydstrup
    DOI:10.1002/chem.201303384
    日期:2013.12.23
    Reaction conditions for the three‐component synthesis of aryl 1,3‐diketones are reported applying the palladium‐catalyzed carbonylative αarylation of ketones with aryl bromides. The optimal conditions were found by using a catalytic system derived from [Pd(dba)2] (dba=dibenzylideneacetone) as the palladium source and 1,3‐bis(diphenylphosphino)propane (DPPP) as the bidentate ligand. These transformations
    据报道,使用钯催化的酮与芳基溴化物的羰基化α-芳基化反应,可以合成芳基1,3-二酮的三组分反应条件。通过使用衍生自[Pd(dba)2 ](dba =二亚苄基丙酮)作为钯源和1,3-双(二苯基膦基)丙烷(DPPP)作为二齿配体的催化体系找到了最佳条件。这些转化是在两室反应器COware中进行的,仅应用了从CO释放化合物9-甲基芴-9-羰基氯(COgen)产生的1.5当量的一氧化碳。该方法论证明可适用于多种芳基和杂芳基溴化物,从而导致多种芳基1,3-二酮。依靠31 P和进行13 C NMR光谱分析以确定可能的催化途径。我们的结果表明,[Pd(dba)2 ]和DPPP的组合仅在存在苯乙酮烯醇钠的情况下才对4-溴苯甲醚具有反应性,这表明[Pd(dppp)(enolate)]阴离子是在生成苯丙酮之前最初生成的。氧化加成步骤。随后将CO插入[Pd(Ar)(dppp)(烯酸酯)]物种中,提供了1,3-二
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐